The AstraZeneca vaccines are licensed and manufactured by the Serum Institute of India and will enable health workers and other priority populations vulnerable to COVID-19 to be protected against the virus, it said.
The shipment of 360,000 Made-in-India COVID
that arrived in Yemen, as part of the first batch of 1.9 million doses it will receive throughout the year, is a "game changer" and a "milestone" in the fight against the pandemic in the country, health officials have said.
Yemen on Wednesday received 360,000 COVID
doses shipped via the COVAX Facility, a partnership between the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine
Alliance, UNICEF and the World Health Organization (WHO), UNICEF said in a statement.
The AstraZeneca vaccines
are licensed and manufactured by the Serum Institute of India and will enable health workers and other priority populations vulnerable to COVID
-19 to be protected against the virus, it said.
The 360,000 doses arrived with 13,000 safety boxes and 1,300,000 syringes that are critical for the safe and effective roll-out of the vaccination campaign. This first batch is part of 1.9 million doses that Yemen will initially receive throughout 2021.
External Affairs Minister S Jaishankar had tweeted: "Arrival in Aden. Made in India vaccines
land in Yemen," with the hashtag "VaccineMaitri".
UNICEF Representative Philippe Duamelle and WHO Representative Dr Adham Ismail took delivery of the vaccines
in Aden, together with the Minister of Health and Population Dr Qasim Buhaibeh, and the Deputy Minister of Public Health and Population Dr Ali Alwaleedi.
"The arrival of the COVID
doses is a critical moment for Yemen," Duamelle said.
-19 continues to claim lives around the world, Yemen now has the capacity to protect those most at risk, including health workers, so that they can safely continue to provide life-saving interventions for children and families. Vaccines
save lives, now let's start getting people vaccinated," he added.
Ismail said the shipment represents an important step in the fight against COVID
-19 in Yemen.
"It will help save lives, including those at highest risk of serious disease, and will help protect the health system. These safe and effective vaccines
will be a game changer, but for the foreseeable future we must continue wearing masks, physically distance and avoid crowds," he said.
Rehan Hafiz, Senior Country Manager Yemen, Gavi, the Vaccine
Alliance expressed delight that Sana'a has received its first COVAX vaccine
"We look forward to the launch of the vaccination campaign. Thanks to the work of the Government of Yemen and of the COVAX partners, and with the support of our donors, we are now able to protect our most vulnerable populations," Hafiz said, adding that their work is only beginning, but the arrival of the first COVAX COVID
-19 doses is a major milestone for Yemen.
COVAX, the vaccines
pillar of the Access to COVID
-19 Tools (ACT) Accelerator, is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine
Alliance (Gavi) and the World Health Organization (WHO) - working in partnership with UNICEF as key implementing partner, as well as civil society organisations, vaccine
manufacturers, the World Bank, and others.
Spokesman for UN Secretary-General Stephane Dujarric also told reporters during the daily press briefing that Yemen received 360,000 vaccine
doses shipped via the COVAX Facility.
, licensed and manufactured by the Serum Institute of India, will enable health workers and other vulnerable populations to be protected against the virus," he said.
Dujarric said the first batch of vaccines
along with 13,000 safety boxes and 1,300,000 syringes are critical for the safe and effective roll-out of the vaccination campaign in the country.
Nearly 2 million doses are expected for Yemen this year, he said.